Day 2, Session VII
New Directions and Opportunities in Epilepsy Research, moderated by Jacqueline French, MD, Professor of Neurology, New York University
This 6 presentation and panel session includes:
- New Directions in Epilepsy Research
Daniel Lowenstein, MD, Robert B. and Ellinor Aird Professor and Vice-Chair of Neurology, Director, UCSF Epilepsy Center, University of California, San Francisco
Starts at 0:32
- The Role of Corporate and Government Partnerships in Developing New Epilepsy Products | Presentations and Panel Discussion moderated by Roger J. Porter, MD
Starts at 33:12
- What Does Big Pharma Look for in a New Drug for Epilepsy?
Santiago Arroyo, MD, PhD, VP, Head of Clinical Research & CMO, Pharmatherapeutics, Worldwide Research & Development, Pfizer Inc.
Starts at 33:47
- What Does Big Pharma Look for in a New Drug for Epilepsy?
Roy E. Twyman, MD, Vice President and Global Head of CNS Development, Janssen Pharmaceuticals R&D
Starts at 42:13
- What Does Medium Sized Epilepsy-Oriented Pharma Look for in a New Drug for Epilepsy?
Michael Gold, MD, Vice-President and Head of the CNS Practice, UCB
Starts at 51:46
- What Does the Device Industry Look for When Considering Developing a New Product in the Epilepsy Space?
Frank Fischer, CEO, NeuroPace, Inc.
Starts at 1:04:35
- What Does Big Pharma Look for in a New Drug for Epilepsy?
>> Next Video:
Day 2, Clinical Stage Drugs